China Medicine Stock Performance
| CHME Stock | USD 0.0002 0.0001 100.00% |
China Medicine holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.23, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning China Medicine are expected to decrease by larger amounts. On the other hand, during market turmoil, China Medicine is expected to outperform it. Use China Medicine jensen alpha, daily balance of power, period momentum indicator, as well as the relationship between the maximum drawdown and day typical price , to analyze future returns on China Medicine.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in China Medicine are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, China Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -13.5 M |
China |
China Medicine Relative Risk vs. Return Landscape
If you would invest 0.01 in China Medicine on September 1, 2024 and sell it today you would earn a total of 0.01 from holding China Medicine or generate 100.0% return on investment over 90 days. China Medicine is currently generating 1.5625% in daily expected returns and assumes 12.5% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than China, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China Medicine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medicine's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Medicine, and traders can use it to determine the average amount a China Medicine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CHME | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.5 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.56 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average China Medicine is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Medicine by adding it to a well-diversified portfolio.
China Medicine Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Medicine, and China Medicine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 2 M | |||
| Shares Outstanding | 23.71 M | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 64.75 M | |||
| EBITDA | 13.41 M | |||
| Cash And Equivalents | 7.85 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 4.05 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 1.97 X | |||
| Cash Flow From Operations | 16.96 M | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 66.84 M | |||
| Retained Earnings | 24.76 M | |||
| Current Asset | 94.2 M | |||
| Current Liabilities | 8.45 M | |||
About China Medicine Performance
By analyzing China Medicine's fundamental ratios, stakeholders can gain valuable insights into China Medicine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Medicine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Medicine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people.Things to note about China Medicine performance evaluation
Checking the ongoing alerts about China Medicine for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Medicine is way too risky over 90 days horizon | |
| China Medicine has some characteristics of a very speculative penny stock | |
| China Medicine appears to be risky and price may revert if volatility continues | |
| China Medicine has high likelihood to experience some financial distress in the next 2 years |
- Analyzing China Medicine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Medicine's stock is overvalued or undervalued compared to its peers.
- Examining China Medicine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Medicine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Medicine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Medicine's pink sheet. These opinions can provide insight into China Medicine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Pink Sheet analysis
When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |